Patents by Inventor Sidney Spector

Sidney Spector has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4151268
    Abstract: Barbituric acid antigens are prepared by coupling 5- or 5,5-substituted barbituric acid to immunogenic carrier materials. In preferred embodiments, proteins are used as the carrier materials and the coupling is effected by an amide linkage between the 5-substituent of the barbituric acid and a carboxyl or amino group of the protein. The resulting antigens produce immunological effects when injected into host animals, including the formation of antibodies specific for 5- and 5,5-substituted barbituric acids. These specific antibodies are useful in bioanalytical techniques for the assay of barbituric acids in biological fluids.
    Type: Grant
    Filed: December 15, 1977
    Date of Patent: April 24, 1979
    Assignee: Hoffmann-La Roche Inc.
    Inventor: Sidney Spector
  • Patent number: 4107157
    Abstract: Barbituric acid antigens are prepared by coupling 5- or 5,5-substituted barbituric acid to immunogenic carrier materials. In preferred embodiments, proteins are used as the carrier materials and the coupling is effected by an amide linkage between the 5-substituent of the barbituric acid and a carboxyl or amino group of the protein. The resulting antigens produce immunological effects when injected into host animals, including the formation of antibodies specific for 5- and 5,5-substituted barbituric acids. These specific antibodies are useful in bioanalytical techniques for the assay of barbituric acids in biological fluids.
    Type: Grant
    Filed: March 23, 1976
    Date of Patent: August 15, 1978
    Assignee: Hoffmann-La Roche Inc.
    Inventor: Sidney Spector
  • Patent number: 4094964
    Abstract: A sensitive immunoassay for clonidine, 2-(2,6-dichloroanilino)-2-imidazoline hydrochloride is described. To prepare the clonidine selective antiserum, an antigen is made comprising 4-[[6-[2,4-dichloro-3(4,5-dihydro-1H-imidazol-2-yl)amino]hydroxyphenyl]azo ]benzoic acid covalently bonded to an immunogenic carrier material through a peptide bond formed from said carboxyl group and amino groups contained in said immunogenic carrier material and the antigen is injected into a suitable host animal to elicit the desired antiserum.
    Type: Grant
    Filed: May 10, 1977
    Date of Patent: June 13, 1978
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Bevyn Jarrott, Sidney Spector
  • Patent number: 4078049
    Abstract: A sensitive immunoassay for acetylcholine is described. To prepare the acetylcholine selective antiserum, an antigen is made comprising 6-aminocaproic acid (2-trimethylaminoethyl) ester covalently bonded to an immunogenic carrier material through a peptide bond formed from said 6-amino group and carboxyl groups contained in said immunogenic carrier material and the antigen is injected into a suitable host animal to elicit the desired antiserum.
    Type: Grant
    Filed: February 28, 1977
    Date of Patent: March 7, 1978
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Arthur Martin Felix, Sidney Spector
  • Patent number: 4070492
    Abstract: New hapten compositions useful in preparing antigens which may be employed in eliciting antibodies useful in immunoassay, particularly radioimmunoassay for propranolol. Utilizing an enantiomer in formation of the hapten allows preparation of an antibody which is able to discriminate between enantiomers selectively.
    Type: Grant
    Filed: March 2, 1977
    Date of Patent: January 24, 1978
    Assignee: Hoffmann-La Roche, Inc.
    Inventor: Sidney Spector
  • Patent number: 4042682
    Abstract: A morphine-like compound (MLC) can be extracted from the brain of various species by utilizing morphine specific antibodies. MLC shows great similarities to morphine in immunological, chemical and chromatographic tests. The compound has biological activity as it inhibits the electrically induced contractions both of the guinea pig ileum and mouse vas deferens but the inhibition is not reversed by naloxone or naltrexone.
    Type: Grant
    Filed: April 7, 1976
    Date of Patent: August 16, 1977
    Assignee: Hoffmann-La Roche Inc.
    Inventor: Sidney Spector
  • Patent number: 4026879
    Abstract: New hapten compositions useful in preparing antigens which may be employed in eliciting antibodies useful in immunoassay, particularly radioimmunoassay for propranolol. Utilizing an enantiomer in formation of the hapten allows preparation of an antibody which is able to discriminate between enantiomers selectively.
    Type: Grant
    Filed: March 23, 1976
    Date of Patent: May 31, 1977
    Assignee: Hoffmann-La Roche Inc.
    Inventor: Sidney Spector
  • Patent number: 3976763
    Abstract: A sensitive radioimmunoassay for chlorpromazine is described. To prepare the chlorpromazine selective antiserum, an antigen is made comprising chlorpromazine covalently bonded to an immunogenic carrier material through a diazo containing linking group and the antigen is injected into a suitable host mammal to elicit the desired antiserum. A preferred linking group is diazophenylcarbonyl while bovine serum albumin is a preferred immunogenic carrier material.
    Type: Grant
    Filed: April 30, 1975
    Date of Patent: August 24, 1976
    Assignee: Hoffmann-La Roche Inc.
    Inventor: Sidney Spector